Pinter A - Search Results

1

FSCPX, a Chemical Widely Used as an Irreversible A₁ Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.

Erdei T, Szabo AM, Lampe N, Szabo K, Kiss R, Zsuga J, Papp C, Pinter A, Szentmiklosi AJ, Szilvassy Z, Juhasz B, Gesztelyi R. Erdei T, et al. Among authors: pinter a. Molecules. 2018 Aug 30;23(9):2186. doi: 10.3390/molecules23092186. Molecules. 2018. PMID: 30200192 Free PMC article.

2

Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.

Zsuga J, Erdei T, Szabó K, Lampe N, Papp C, Pinter A, Szentmiklosi AJ, Juhasz B, Szilvássy Z, Gesztelyi R. Zsuga J, et al. Among authors: pinter a. Molecules. 2017 May 19;22(5):839. doi: 10.3390/molecules22050839. Molecules. 2017. PMID: 28534854 Free PMC article.

3

An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A₁ Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium.

Szabo AM, Erdei T, Viczjan G, Kiss R, Zsuga J, Papp C, Pinter A, Juhasz B, Szilvassy Z, Gesztelyi R. Szabo AM, et al. Among authors: pinter a. Molecules. 2019 Jun 12;24(12):2207. doi: 10.3390/molecules24122207. Molecules. 2019. PMID: 31212849 Free PMC article.

4

Accuracy and Precision of the Receptorial Responsiveness Method (RRM) in the Quantification of A₁ Adenosine Receptor Agonists.

Szabo AM, Viczjan G, Erdei T, Simon I, Kiss R, Szentmiklosi AJ, Juhasz B, Papp C, Zsuga J, Pinter A, Szilvassy Z, Gesztelyi R. Szabo AM, et al. Among authors: pinter a. Int J Mol Sci. 2019 Dec 12;20(24):6264. doi: 10.3390/ijms20246264. Int J Mol Sci. 2019. PMID: 31842299 Free PMC article.

5

The influence of affinity, efficacy, and slope factor on the estimates obtained by the receptorial responsiveness method (RRM): a computer simulation study.

Grenczer M, Pinter A, Zsuga J, Kemeny-Beke A, Juhasz B, Szodoray P, Tosaki A, Gesztelyi R. Grenczer M, et al. Among authors: pinter a. Can J Physiol Pharmacol. 2010 Nov;88(11):1061-73. doi: 10.1139/y10-078. Can J Physiol Pharmacol. 2010. PMID: 21076494

6

Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.

Grenczer M, Zsuga J, Majoros L, Pinter A, Kemeny-Beke A, Juhasz B, Tosaki A, Gesztelyi R. Grenczer M, et al. Among authors: pinter a. Can J Physiol Pharmacol. 2010 Nov;88(11):1074-83. doi: 10.1139/y10-089. Can J Physiol Pharmacol. 2010. PMID: 21076495

7

Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).

Pinter A, Eyerich K, Costanzo A, Garrelts A, Schuster C, Mert C, Lampropoulou A, Fotiou K, Maul JT, Papp KA. Pinter A, et al. J Dermatolog Treat. 2024 Dec;35(1):2350227. doi: 10.1080/09546634.2024.2350227. Epub 2024 May 26. J Dermatolog Treat. 2024. PMID: 38797734

8

Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data.

Pinter A, Soliman AM, Manz KC, Weber V, Ludwig P, Mocek A, Höer A, Lebwohl MG. Pinter A, et al. Dermatol Ther (Heidelb). 2024 May 24. doi: 10.1007/s13555-024-01172-6. Online ahead of print. Dermatol Ther (Heidelb). 2024. PMID: 38787476

9

S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.

Zouboulis CC, Bechara FG, Fritz K, Goebeler M, Hetzer FH, Just E, Kirsten N, Kokolakis G, Kurzen H, Nikolakis G, Pinter A, Podda M, Rosinski K, Schneider-Burrus S, Taube KM, Volz T, Winkler T, Kristandt A, Presser D, Zouboulis VA. Zouboulis CC, et al. Among authors: pinter a. J Dtsch Dermatol Ges. 2024 May 21. doi: 10.1111/ddg.15412. Online ahead of print. J Dtsch Dermatol Ges. 2024. PMID: 38770982

10

Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan.

Tada Y, Soliman AM, Ishii K, Sakuma R, Pinter A, Davis M, Nunag D, Buessing M, Puig L, Imafuku S. Tada Y, et al. Among authors: pinter a. Exp Dermatol. 2024 May;33(5):e15067. doi: 10.1111/exd.15067. Exp Dermatol. 2024. PMID: 38757460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

668 results

Search Page